New service!

Standard Selectivity Profiling

We’re happy to introduce our latest addition to our service portfolio; Standard Selectivity Profiling
Whether you are a pharmaceutical company, biotech company or academia – the struggle to identify early liabilities, to proceed with the safest lead candidates, is the same.
With a proteome coverage of more than 5,000 proteins and a turnaround time of just 10 days, our new unbiased selectivity profiling service helps you prioritize your compounds or series, based on off-target engagement.

Matrix: Proprietary lysate stemming from a human suspension cancer cell line
Requirements: 50 µL in DMSO at 10 mM
Reproducibility: 93-97%